Echinacea angustifolia, commonly known as narrow-leaved coneflower, contains bioactive compounds, such as alkamides, polysaccharides, and flavonoids, which have demonstrated various pharmacological activities. Studies have shown that Echinacea angustifolia extracts may possess immunomodulatory properties, stimulating immune cell activity and promoting a balanced immune response. This is relevant in the context of combating tick-borne pathogens and supporting the body’s defense against Lyme disease. Additionally, the plant’s constituents have shown anti-inflammatory effects, which is beneficial in managing the inflammatory responses associated with tick-borne infections.
- Immunomodulatory effects: Echinacea has been shown to modulate immune system activity, potentially boosting immune response against infections. This property may help support the body’s defenses in fighting tick-borne diseases.
- Antimicrobial activity: Echinacea extracts have demonstrated broad-spectrum antimicrobial activity against various pathogens. While the specific effects of echinacea on the bacteria causing tick-borne diseases are not well-studied, it may have potential in inhibiting the growth of certain bacteria and supporting the body’s natural defenses.
- Anti-inflammatory properties: Tick-borne diseases often result in inflammation, which contributes to symptoms and complications. Echinacea has shown anti-inflammatory effects that may help reduce inflammation associated with these conditions.
Echinacea has been studied for its potential to increase white blood cell (WBC) count, which is an important component of the immune system. Raus K et al. (2009): This study investigated the effect of an echinacea extract on immune parameters in healthy subjects. The researchers observed a significant increase in WBC count after 5 days of treatment with echinacea compared to the placebo group.